{"disease":{"id":"hematopoietic","name":"hematopoietic"},"drugs":{"marketed":[{"drug_id":"narsoplimab","indication_name":"hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Yartemlea","generic_name":"NARSOPLIMAB","company_name":"Omeros Corp","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":40,"revenue":null,"mechanism":"Narsoplimab works by targeting and modulating the immune system to prevent damage to blood vessels."},{"drug_id":"plerixafor","indication_name":"Peripheral Mobilization of Hematopoietic Stem Cells","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mozobil","generic_name":"plerixafor","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"C-C chemokine receptor type 2","drug_class":"Hematopoietic Stem Cell Mobilizer [EPC]","quality_score":61,"revenue":null,"mechanism":"Mozobil works by binding to the C-C chemokine receptor type 2, which helps to mobilize hematopoietic stem cells from the bone marrow into the bloodstream."},{"drug_id":"busilvex","indication_name":"Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Busilvex","company_name":"medac GmbH","drug_phase":"phase_2","molecular_target":"Matrix metalloproteinase-9","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"mozobil","indication_name":"Peripheral Mobilization of Hematopoietic Stem Cells","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Mozobil","company_name":"University of Washington","drug_phase":"marketed","molecular_target":"Stromal cell-derived factor 1, Atypical chemokine receptor 3, C-C chemokine receptor type 2","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"mycophenolate-mofetil","indication_name":"The suppression of graft-versus-host disease in hematopoietic stem cell transplantation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cellcept","generic_name":"MYCOPHENOLATE MOFETIL","company_name":"Roche Palo","drug_phase":"marketed","molecular_target":"Inosine-5'-monophosphate dehydrogenase 2","drug_class":"Antimetabolite Immunosuppressant","quality_score":10,"revenue":null,"mechanism":"Cellcept works by inhibiting the enzyme inosine-5'-monophosphate dehydrogenase 2, which is necessary for the production of guanosine nucleotides."},{"drug_id":"busulfan","indication_name":"Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Busulfex","generic_name":"busulfan","company_name":"Waylis","drug_phase":"marketed","molecular_target":"Matrix metalloproteinase-9","drug_class":"Alkylating Drug [EPC]","quality_score":10,"revenue":null,"mechanism":"Busulfex works by attaching an alkyl group to the DNA of cancer cells, interfering with their ability to replicate and ultimately leading to cell death."},{"drug_id":"busulfex","indication_name":"Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"busulfex","company_name":"Dana-Farber Cancer Institute","drug_phase":"marketed","molecular_target":"Matrix metalloproteinase-9","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"busulphan","indication_name":"Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Busulphan","company_name":"University of Birmingham","drug_phase":"discontinued","molecular_target":"Matrix metalloproteinase-9","drug_class":"","quality_score":null,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":8,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03892967","title":"Enhanced, EHR-facilitated Cancer Symptom Control Pragmatic Clinical Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":50207,"lead_sponsor_name":"Mayo Clinic","has_results":true},{"nct_id":"NCT04494945","title":"Identifying and Caring for Individuals With Inherited Cancer Syndrome","phase":"NA","overall_status":"RECRUITING","enrollment_count":27500,"lead_sponsor_name":"OHSU Knight Cancer Institute","has_results":false},{"nct_id":"NCT04500600","title":"Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":13378,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT01772771","title":"Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT07349498","title":"Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT02465060","title":"Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6452,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06304168","title":"Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study","phase":"","overall_status":"RECRUITING","enrollment_count":6150,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT07325006","title":"Impact of Physician Behavior on Cancer Distress","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT02474160","title":"Collection and Storage of Tissue and Blood Samples From Patients With Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"National Cancer Institute LAO","has_results":false},{"nct_id":"NCT00991094","title":"Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT00736749","title":"Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT06708130","title":"Allogeneic Hematopoietic Stem Cell Transplantation Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT05112614","title":"Role of Gut Microbiome in Cancer Therapy","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05364086","title":"An Observational Research Study for Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2100,"lead_sponsor_name":"University of Rochester NCORP Research Base","has_results":false},{"nct_id":"NCT05334069","title":"Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Alliance for Clinical Trials in Oncology","has_results":false},{"nct_id":"NCT03000244","title":"Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06295965","title":"Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"University of Washington","has_results":false},{"nct_id":"NCT07126496","title":"A Virtual Community Health Educator for Increasing Clinical Trial Referrals Among Cancer Patients and Their Caregivers","phase":"NA","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT02958462","title":"Pre-myeloid Cancer and Bone Marrow Failure Clinic Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT04387656","title":"NCI COVID-19 in Cancer Patients, NCCAPS Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1877,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT01602211","title":"INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1600,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":false},{"nct_id":"NCT05132842","title":"Cannabis Use Patterns Among Cancer Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1568,"lead_sponsor_name":"Thomas Jefferson University","has_results":false},{"nct_id":"NCT07215039","title":"Improving Prison Health Equity Through Cancer Literacy and Screening Awareness in Florida","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1200,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT07412002","title":"Quality of End-of-Life Care for Children With Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1190,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT06353191","title":"Biomarkers to Predict Cancer Therapy-related Cardiotoxicity","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT07205523","title":"High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Yigeng Cao,MD,PhD","has_results":false},{"nct_id":"NCT03357172","title":"Determination of Factors Involved in the Regulation of Immune Responses After Allogeneic Hematopoietic Stem Cell Transplantation","phase":"NA","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT06198010","title":"A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors","phase":"NA","overall_status":"RECRUITING","enrollment_count":660,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT00674882","title":"Protocol For Collecting Long-Term Follow-Up Data On Recipients of Bone Marrow and Blood Stem Cell Transplant","phase":"","overall_status":"COMPLETED","enrollment_count":637,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT04592250","title":"Financial Toxicity in Cancer Patients","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":625,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT03207854","title":"Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers","phase":"","overall_status":"RECRUITING","enrollment_count":625,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT06279013","title":"Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment","phase":"NA","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"NRG Oncology","has_results":false},{"nct_id":"NCT04551378","title":"The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT07463651","title":"MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":594,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT04630431","title":"Understanding Challenges, Behavioral Patterns, and Preferences Toward Participation in Clinical Trials in Minority Patient Populations: Development of a Personalized Clinical Trial Educational Platform to Increase Participation in Clinical Trials Among Underserved Cancer Patients","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":590,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT07290543","title":"Web-Based Toolkit to Improve Cancer-Related Emotional Distress and Anxiety in Rural Older Cancer Survivors","phase":"NA","overall_status":"RECRUITING","enrollment_count":578,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT04593277","title":"Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":549,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":false},{"nct_id":"NCT05228275","title":"Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":549,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT03125070","title":"Self-Management Program and Survivorship Care Plan in Improving the Health of Cancer Survivors After Stem Cell Transplant","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":546,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":true},{"nct_id":"NCT02847130","title":"Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology","phase":"","overall_status":"COMPLETED","enrollment_count":530,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT01877655","title":"A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":514,"lead_sponsor_name":"Astellas Pharma Global Development, Inc.","has_results":true},{"nct_id":"NCT04786002","title":"Target Busulfan Exposure in Children With HSCT in China","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT07028112","title":"Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematopoietic Stem-Cell Transplantation.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05090345","title":"A Prospective Registry of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS).","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT05722210","title":"Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT03870750","title":"Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":458,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":false},{"nct_id":"NCT04788420","title":"Influence of Co-existing Mutations on Sorafenib Maintenance Therapy After Allo-HSCT for Patients With FLT3-ITD AML","phase":"","overall_status":"COMPLETED","enrollment_count":456,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT06673459","title":"BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":430,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT04409236","title":"Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":427,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":false},{"nct_id":"NCT03996265","title":"Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":422,"lead_sponsor_name":"University of Rochester NCORP Research Base","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}